TBC1D19 Activators comprise a diverse group of chemical compounds that influence cellular signaling pathways, potentially leading to the modulation of TBC1D19 activity. While these activators do not directly bind or interact with TBC1D19, their actions within the cell create a biochemical environment that can lead to its activation. For instance, compounds that increase intracellular cAMP levels, such as Forskolin, IBMX, Epinephrine, PGE2, 8-Br-cAMP, and Dibutyryl-cAMP, do so by either stimulating adenylate cyclase, inhibiting phosphodiesterases, or mimicking cAMP itself. This elevation in cAMP may then influence pathways that converge on TBC1D19.
On the other hand,chemicals altering intracellular calcium levels, like A23187 (Calcimycin), Thapsigargin, and Ionomycin, indirectly affect TBC1D19 by perturbing the calcium-dependent signaling pathways. Phorbol esters and Rolipram represent another class of compounds; the former directly activates protein kinase C, which is a key player in multiple signaling cascades, while the latter inhibits phosphodiesterase 4 enhancing cAMP levels. These changes in cellular signaling can lead to the modification of TBC1D19 activity through complex signaling networks. Collectively, these chemicals, by modulating the cellular signaling machinery, have the potential to influence TBC1D19 activation, making them indirect activators of this protein.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin is a diterpene produced by the Indian Coleus plant. It activates adenylate cyclase, increasing levels of cyclic AMP (cAMP) in cells, which can modulate various signaling pathways that might indirectly activate TBC1D19. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective inhibitor of phosphodiesterases. It prevents the breakdown of cAMP and cGMP, thereby potentially affecting signaling pathways that could indirectly activate TBC1D19. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine, also known as adrenaline, is a hormone that, among its various functions, can trigger signaling cascades via adrenergic receptors leading to increased cAMP levels, which may influence TBC1D19 activity. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Prostaglandin E2 functions by activating its G-protein-coupled receptors, leading to an increase in intracellular cAMP, which could impact signaling pathways involving TBC1D19. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
8-Bromoadenosine 3',5'-cyclic monophosphate (8-Br-cAMP) is a cell-permeable cAMP analog. It activates cAMP-dependent pathways, which might indirectly result in the activation of TBC1D19. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is an ionophore that raises intracellular calcium levels, which can influence multiple signaling pathways and potentially affect TBC1D19 activity. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a non-competitive inhibitor of the sarco/endoplasmic reticulum Ca2+ ATPase (SERCA), causing an increase in cytosolic calcium levels, which may indirectly influence TBC1D19 activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is an ionophore that specifically binds to and transports calcium ions across membranes, which can alter intracellular signaling pathways that might indirectly activate TBC1D19. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl-cAMP is a cell-permeable analog of cAMP. It activates cAMP-dependent pathways in a manner similar to cAMP, potentially leading to indirect activation of TBC1D19. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a selective inhibitor of phosphodiesterase 4 (PDE4), leading to an increase in intracellular cAMP concentrations, which may indirectly influence TBC1D19 activity. | ||||||